Mohammad Owais
Impact in
- Pharmaceutical Science top 2%
Papers in
-
- RNA Interference and Gene Delivery 15
- Immunology 37
- Immunotherapy and Immune Responses 12
- Co-authors
- Mohammad Asif Sherwani (20 shared papers)Farrukh Aqil (3 shared papers)Chhitar M. Gupta (6 shared papers)Syed Mohd Faisal (14 shared papers)Iqbal Ahmad (1 shared paper)Mohd Ahmar Rauf (11 shared papers)M. Saleemuddin (6 shared papers)Mohammad Shakir (12 shared papers)
- Journals
- Vaccine (11 papers)Journal of drug targeting (10 papers)International Journal of Biological Macromolecules (9 papers)PLoS ONE (8 papers)RSC Advances (5 papers)
- Partner nations
- IndiaSaudi ArabiaUnited States
In The Last Decade
Mohammad Owais
201 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 146
- Complementary and alternative medicine 275
- Pharmaceutical Science 211
- Biomaterials 427
- Organic Chemistry 836
- Molecular Medicine 124
Countries citing papers authored by Mohammad Owais
This map shows the geographic impact of Mohammad Owais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Owais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Owais more than expected).
Fields of papers citing papers by Mohammad Owais
This network shows the impact of papers produced by Mohammad Owais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Owais. The network helps show where Mohammad Owais may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Owais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modern phytomedicine: Turning Medicinal Plants into Drugs | 2006 | 212 |
| 2 | 2018 | 185 | |
| 3 | 2016 | 158 | |
| 4 | 2004 | 145 | |
| 5 | 2013 | 129 | |
| 6 | 2011 | 128 | |
| 7 | 2022 | 127 | |
| 8 | 2013 | 122 | |
| 9 | 2005 | 118 | |
| 10 | 2017 | 116 | |
| 11 | 2012 | 108 | |
| 12 | 2015 | 106 | |
| 13 | 2015 | 81 | |
| 14 | 1995 | 74 | |
| 15 | 2016 | 72 | |
| 16 | 2007 | 52 | |
| 17 | 2000 | 50 | |
| 18 | 2005 | 50 | |
| 19 | 2005 | 49 | |
| 20 | 2019 | 48 |
About Mohammad Owais
Mohammad Owais is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Organic Chemistry and Materials Chemistry, having authored 208 papers that have together received 5.0k indexed citations. Recurring topics across this work include Synthesis and biological activity (17 papers), Nanoparticles: synthesis and applications (16 papers), RNA Interference and Gene Delivery (15 papers), Antifungal resistance and susceptibility (15 papers), Immunotherapy and Immune Responses (12 papers), Synthesis and Characterization of Heterocyclic Compounds (12 papers), Antimicrobial Peptides and Activities (10 papers) and Metal complexes synthesis and properties (10 papers). The work is most often cited by research in Complementary and alternative medicine (275 citations), Pharmaceutical Science (211 citations), Biomaterials (427 citations), Organic Chemistry (836 citations) and Molecular Medicine (124 citations). Mohammad Owais has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Mohammad Asif Sherwani, Farrukh Aqil, Chhitar M. Gupta, Syed Mohd Faisal, Iqbal Ahmad, Mohd Ahmar Rauf, M. Saleemuddin, Mohammad Shakir, Masood Alam Khan and Aijaz Ahmed Khan. Their work appears in journals such as Vaccine, Journal of drug targeting, International Journal of Biological Macromolecules, PLoS ONE and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.